Last reviewed · How we verify
BAY1834845
At a glance
| Generic name | BAY1834845 |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Nasopharyngitis
- Diarrhoea
- Blood creatine phosphokinase increased
- Eczema
- Tachycardia
- Periorbital oedema
- Tongue oedema
- Vomiting
- Palatal oedema
- Palatal swelling
- Pyrexia
- Gastroenteritis viral